Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial import inner membrane translocase subunit Tim29 (TIMM29) is an integral membrane protein specifically found in metazoans and is a component of the TIM22 complex, which is essential for importing and inserting multi-pass transmembrane proteins, such as metabolite carriers, into the mitochondrial inner membrane[1][2][4][5]. Tim29 is necessary for the assembly and stability of the TIM22 complex and also physically links the TIM22 complex with the translocase of the outer mitochondrial membrane (TOM), thereby coordinating import across both mitochondrial membranes[1][2][5]. Loss of TIMM29 impairs the stability of the TIM22 complex and disrupts mitochondrial protein homeostasis, which may contribute to human diseases linked to mitochondrial protein import dysfunction, such as neurodegenerative disorders and some metabolic syndromes[1][2][5]. TIMM29 is not known to interact directly with any therapeutic drugs, nor is it currently considered a direct therapeutic target, but may be of interest in research concerning mitochondrial disorders, import machineries, and related pathologies[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit Tim29 (TIMM29).